Australia's Optiscan Imaging rises on collaboration with US-based firm
ReutersJun 23, 2025 2:39 AM
Shares of medical device maker Optiscan Imaging OIL.AX rise 9.1% to A$0.120, on track for best day since May 29, if gains hold
Co signs a collaboration agreement with U.S.-based private firm Long Grove Pharmaceuticals
Under deal, Long Grove's fluorescein drug will be used in clinical studies and trials with co's InVue surgical imaging device
Says data from the collaboration studies to be used for U.S. FDA regulatory approvals submissions for the device
Stock down 22.6%, YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
New Fed Chair Warsh Takes Office: Major Shift in Monetary Policy? US Dollar Short-Term Rebound, 2026 Investment Strategy Analysis
TradingKey - At the start of 2026, global financial markets witnessed a major leadership change as U.S. President Trump officially nominated Kevin Warsh as the next Federal Reserve Chair. Pending Senate confirmation, he will succeed Jerome Powell this May to lead the world’s most influential central bank.TradingKey
5 hours ago
Should You Buy Berkshire Hathaway Post-Warren Buffett? What's Warren Buffett's Advice for 2026 Investment?
Berkshire built up a hoard of cash through 2025, accumulating nearly $400 billion—more than it had ever held before. That was by design. Berkshire, instead of joining the artificial intelligence rally that led the headlines, put the cash into short-term U.S. Treasuries with about 3.6% yields.TradingKey
13 hours ago
Digital Asset Rotation: Navigating Market Volatility With the Best Cheap Cryptos for 2026
Navigate the 2026 crypto rotation: Analyze the best cheap cryptos like Solana, Chainlink, and XRP amid Bitcoin’s volatility. Discover top picks for utility and long-term gains.TradingKey
Wed, Feb 18
